PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma.

Saved in:
Bibliographic Details
Title: PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma.
Authors: Heuer S; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany., Burghaus I; Coordination Centre for Clinical Trials (KKS) Heidelberg, 69120, Heidelberg, Germany., Gose M; Coordination Centre for Clinical Trials (KKS) Heidelberg, 69120, Heidelberg, Germany., Kessler T; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany., Sahm F; Department of Neuropathology, University Hospital Heidelberg, INF 224, 69120, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), Geman Cancer Research Center (DKFZ), Heidelberg, Germany., Vollmuth P; Department of Neuroradiology, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany., Venkataramani V; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Department of Functional Neuroanatomy, Institute for Anatomy and Cell Biology, Heidelberg University, Heidelberg, Germany., Hoffmann D; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany., Schlesner M; German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Biomedical Informatics, Data Mining and Data Analytics, University of Augsburg, Augsburg, Germany., Ratliff M; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Neurosurgery Clinic, University Hospital Mannheim, 68167, Mannheim, Germany., Hopf C; Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Paul-Wittsack Str. 10, 68163, Mannheim, Germany.; Medical Faculty, Heidelberg University, Heidelberg, Germany.; Mannheim Center for Translational Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany., Herrlinger U; Division of Clinical Neurooncology, Department of Neurology and Centre of Integrated Oncology, University Hospital Bonn, Bonn, Germany., Ricklefs F; Department of Neurosurgery, University Hospital Eppendorf, Martinistr. 52, 20246, Hamburg, Germany., Bendszus M; Department of Neuroradiology, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany., Krieg SM; Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany., Wick A; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany., Wick W; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany., Winkler F; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany. Frank.Winkler@med.uni-heidelberg.de.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. Frank.Winkler@med.uni-heidelberg.de.
Source: BMC cancer [BMC Cancer] 2024 Jan 26; Vol. 24 (1), pp. 135. Date of Electronic Publication: 2024 Jan 26.
Publication Type: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Equivalence Trial
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38279087
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Heuer+S%22">Heuer S</searchLink>; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Burghaus+I%22">Burghaus I</searchLink>; Coordination Centre for Clinical Trials (KKS) Heidelberg, 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Gose+M%22">Gose M</searchLink>; Coordination Centre for Clinical Trials (KKS) Heidelberg, 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Kessler+T%22">Kessler T</searchLink>; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Sahm+F%22">Sahm F</searchLink>; Department of Neuropathology, University Hospital Heidelberg, INF 224, 69120, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), Geman Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Vollmuth+P%22">Vollmuth P</searchLink>; Department of Neuroradiology, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Venkataramani+V%22">Venkataramani V</searchLink>; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Department of Functional Neuroanatomy, Institute for Anatomy and Cell Biology, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hoffmann+D%22">Hoffmann D</searchLink>; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schlesner+M%22">Schlesner M</searchLink>; German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Biomedical Informatics, Data Mining and Data Analytics, University of Augsburg, Augsburg, Germany.<br /><searchLink fieldCode="AU" term="%22Ratliff+M%22">Ratliff M</searchLink>; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Neurosurgery Clinic, University Hospital Mannheim, 68167, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Hopf+C%22">Hopf C</searchLink>; Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Paul-Wittsack Str. 10, 68163, Mannheim, Germany.; Medical Faculty, Heidelberg University, Heidelberg, Germany.; Mannheim Center for Translational Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Herrlinger+U%22">Herrlinger U</searchLink>; Division of Clinical Neurooncology, Department of Neurology and Centre of Integrated Oncology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Ricklefs+F%22">Ricklefs F</searchLink>; Department of Neurosurgery, University Hospital Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Bendszus+M%22">Bendszus M</searchLink>; Department of Neuroradiology, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Krieg+SM%22">Krieg SM</searchLink>; Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Wick+A%22">Wick A</searchLink>; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Wick+W%22">Wick W</searchLink>; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Winkler+F%22">Winkler F</searchLink>; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany. Frank.Winkler@med.uni-heidelberg.de.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. Frank.Winkler@med.uni-heidelberg.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2024 Jan 26; Vol. 24 (1), pp. 135. <i>Date of Electronic Publication: </i>2024 Jan 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Equivalence Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38279087
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12885-024-11846-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 135
    Titles:
      – TitleFull: PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Heuer S
      – PersonEntity:
          Name:
            NameFull: Burghaus I
      – PersonEntity:
          Name:
            NameFull: Gose M
      – PersonEntity:
          Name:
            NameFull: Kessler T
      – PersonEntity:
          Name:
            NameFull: Sahm F
      – PersonEntity:
          Name:
            NameFull: Vollmuth P
      – PersonEntity:
          Name:
            NameFull: Venkataramani V
      – PersonEntity:
          Name:
            NameFull: Hoffmann D
      – PersonEntity:
          Name:
            NameFull: Schlesner M
      – PersonEntity:
          Name:
            NameFull: Ratliff M
      – PersonEntity:
          Name:
            NameFull: Hopf C
      – PersonEntity:
          Name:
            NameFull: Herrlinger U
      – PersonEntity:
          Name:
            NameFull: Ricklefs F
      – PersonEntity:
          Name:
            NameFull: Bendszus M
      – PersonEntity:
          Name:
            NameFull: Krieg SM
      – PersonEntity:
          Name:
            NameFull: Wick A
      – PersonEntity:
          Name:
            NameFull: Wick W
      – PersonEntity:
          Name:
            NameFull: Winkler F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 01
              Text: 2024 Jan 26
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1471-2407
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC cancer
              Type: main
ResultId 1